Get started
Bionano Genomics, Inc.Bionano Genomics, Inc.Bionano Genomics, Inc.

Bionano Genomics, Inc.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

BNGO trade ideas

Bionano in trouble? Bionano Short Term - We look to Sell at 1.78 (stop at 2.04) Preferred trade is to sell into rallies. The trend of lower highs is located at 1.85. Our outlook is bearish. We have a 38.2% Fibonacci pullback level of 1.80 from 2.84 to 1.18. Bespoke resistance is located at 1.85. Our profit targets will be 1.18 and 1.01 Resistance: 1.85 / 2.50 / 3.00 Support: 1.50 / 1.00 / 0.50 Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features. Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
NASDAQ:BNGOShort
by Saxo
BNGO Ready to Break? Bionano Genomics - Short Term - We look to Buy a break of 2.52 (stop at 2.25) A break of yesterdays high would confirm bullish momentum. Posted a Double Bottom formation. The measured move target is 3.36. We look for gains to be extended today. Our profit targets will be 3.13 and 3.30 Resistance: 2.50 / 3.00 / 4.00 Support: 2.00 / 1.70 / 1.50 Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features. Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
NASDAQ:BNGOLong
by Saxo
BNGO Good News Coming Soon?NASDAQ:BNGO [/symbol With recent news, the future is looking good for BNGO. Biden signed ALS Law, this will result in $100m a year going into R&D for therapeutics and treatment; for ALS. Mayo clinic, a ALS Clinic, is already using BNGO. As well there is a projected 1500+ attendees at the moment for Symposiums2022. With pictures of the new system set to come out soon, On December 30, 2021, Bionano Genomics, entered into a Standard Industrial/Commercial Single-Tenant Lease with 6777 Nancy Ridge LLC. The Company agreed to lease from Landlord approximately 11,978 rentable square feet of laboratory and office space. Many fear that this was a costly play, not suitable for the current state of BNGO. Current Options Positions Short Calls - Strike 5.00 @ 1.21, 21-01-2022 Long Puts - Strike 2.00 @ 0. 05 , 21-01-2022 Short Calls - Strike 6.00 @0.21, 21-01-2022 Current Stock Positions @5.97 @4.00 @3.69 Average Price: 4.3425
NASDAQ:BNGO
by braydenboyko
20 layer dip 🚨bngo stuck in this downtrend channel with no signs of a breakout anytime soon.. unfortunately that has been the case for most penny stocks this year, many of them wont rally back to highs for a few years.. thats if they even end up coming back. l'd consider a long position if it broke top trendline resistance. but for now we can clearly see lower highs repeating, every pop gets weaker. not a good sign if your a long or want to take a long. like and follow for more 💘
NASDAQ:BNGOShort
by Vibranium_Capital
3
BNGO Fairly Priced?NASDAQ:BNGO BNGO has seen a steady decline over the last 8 months, you can read my past articles for the reasoning for this. I believe we have now found our fair value of this company. the stock has been steadily holding the $3.00 line for the last one and a half weeks. It has as well been hovering around the oversold (30) on the RSI index. After bears have been manipulating the prices down, it has become clear the mood has shifted. Will we have a Christmas run? I don't believe so, but I believe the new year will be positive prior to the tapering. If you are holding this company for years, the short term price should not matter to you, unless it means you can purchase more! Best of luck all and happy holidays! Current Options Positions Short Calls - Strike 5.00 @ 1.21, 21-01-2022 Long Puts - Strike 2.00 @ 0. 05 , 21-01-2022 Short Calls - Strike 6.00 @0.21, 21-01-2022 Current Stock Positions @5.97 @4.00 @3.69 Average Price: 4.3425
NASDAQ:BNGOLong
by braydenboyko
BNGO Holding The Line. NASDAQ:BNGO With the entire market red today, it is no surprise that BNGO was down. But I see some positives here. BNGO typically has seen enormous drops when the market is red, I relate this to it's high beta (1.87). Today however, BNGO did not see a dramatic drop, instead it stays near the $3.44 to $4.29 range. As I previously mentioned, I think it is important for BNGO to hold these levels. I believe it fails to do so this week, we will see the mid $2 levels by the end of the year. I will continue to buy up shares at this discounted price and hedge in the short term. I will continue to sell covered calls, to generate income in these uncertain times. Good luck to all! Current Options Positions Short Calls - Strike 5.00 @ 1.21, 21-01-2022 Long Puts - Strike 2.00 @ 0.05, 21-01-2022 Short Calls - Strike 6.00 @0.21, 21-01-2022 Current Stock Positions @5.97 @4.00 @3.69 Average Price: 4.3425
NASDAQ:BNGOLong
by braydenboyko
BNGO Gaps, Where Will It Stop?NASDAQ:BNGO Well here we are...In my previous articles I have discussed the long term outlook and the short term outlook of BNGO. For the short term I have been right thus far. I want to talk about a few key factors in the last few days. Many investors have noticed price manipulation in stocks, BNGO included. There is a government investigation going on regarding it. Many investors are calling for the removal of Erik Holmlin. The RSI Indicator suggests that BNGO is oversold coming in at 28.57 today. It has been oversold since November 22, 2021. When looking at the supertrend of EMA50 we can see the huge gap in current price to 50 term average. An even larger gap is found on the 100EMA. For the 50 EMA I suggest we would need to see a 34% increase in share price to confirm a reversal, this is in the short term. This number may come down with a few green days. I believe we need a week of majority green to hold the current range of $3.44 - $4.29 Range. If we see a red week starting Monday I believe we will fall into the $2.57 - $3.44 range. Knowing how fast this stock can fall, we could have some low levels as indicated by the levels above. I worry for the short term price of this stock, will the company be able to sustain such low earnings and exposure? Current Options Positions Short Calls - Strike 5.00 @ 1.21, 21-01-2022 Long Puts - Strike 2.00 @ 0.05, 21-01-2022 Short Calls - Strike 6.00 @0.21, 21-01-2022 Current Stock Positions @5.97 @4.00 @3.69 Average Price: 4.3425
NASDAQ:BNGO
by braydenboyko
BNGO Sell Off TodayNASDAQ:BNGO OANDA:US2000USD BNGO down 5.63%...time to panic? Absolutely not, after the rally of small caps over the last two days, it is expected to see a pull back. Short term traders are locking in profits, and volatility was low today (only 5.6Mil). I expect to see the climb of BNGO through the holiday season. Current Options Positions Short Calls - Strike 5.00 @ 1.21, 21-01-2022 Long Puts - Strike 2.00 @ 0.05, 21-01-2022 Short Calls - Strike 6.00 @0.21, 21-01-2022 Current Stock Positions @5.97 @4.00 @3.69
NASDAQ:BNGOLong
by braydenboyko
Have We Found The Bottom?? BNGONASDAQ:BNGO Wow...What a tremendous day for BNGO. What's causing this sudden price spike? Are Investors pouring back into the company? Are we seeing a pump? BNGO has been oversold since November 22, 2021, finally it appears that the bleeding is over. Now investors should not get to excited, with the steady decline over the last 8 months, this could just be a green day, and the trend could continue. This could be institutions bull trapping investors. We will know tomorrow if this is the start of a trend reversal. FDA approval could be excellent timing to see an end of the year run, bull sentiment is up 1.28% according to StockTwits. I believe BNGO has faced manipulation, for this reason it has been down in the dumps. As I have always said, everything in finance is fairly priced, and companies stocks will eventually match that fair price. We must understand that the company needs to boost their revenues to sustain long term growth (as mentioned in my previous article), but I believe a time frame of 3-5 years will be bright for the company. With interest rates hiking in 2022, growth stocks may see a decline. This market has many odds stacked against BNGO, but the company has strong financial background, and a revolutionary product. If it can withstand the beatdown, it will fly. Current Options Positions Short Calls - Strike 5.00 @ 1.21, 21-01-2022 Long Puts - Strike 2.00 @ 0.05, 21-01-2022 Short Calls - Strike 6.00 @0.21, 21-01-2022 Current Stock Positions @5.97 @4.00 @3.70 - Most recent addition Average Price: 4.3425
NASDAQ:BNGOLong
by braydenboyko
2
When Will The Bleeding End For BNGO?NASDAQ:BNGO As previously discussed, the long term outlook for BNGO is magnificent. With strong financial management and a revolutionary product, the company is set to break the BioTech industry. So why is the stock doing so poorly in the short term? The company has done very little in sales and has not marketed itself well. It is as simple as that; until the company can find ways to increase earnings, investors will not value them as more than a $2-$3 stock. The company has seen consistent growth in revenue over the last 7 quarters. from 1.14M in Q1 2020 to 4.66M in Q3 of 2021. The growth consistency is something all investors look for in growing companies. I believe we will truly begin to see if BNGO will continue to grow over the next three quarters. It is important to note that small cap stocks have been hit hard by these high inflation periods, as they tend to be growth stocks. If investors do not have the stomach for this market, BNGO is not the play. But investors who are willing to continue to hold, perhaps selling options to generate income, will be rewarded when this company breaks out. The company holds $326 Million in cash, at their current spending rate they must make big plays to increase revenue within the next 8 quarters. It is important to note that BNGO has begun buying smaller BioTech companies, as a result their cash may dwindle far faster than anticipated. This is why I offer the suggestion, that we will know where this company is headed within three to four quarters. My Positions: Today I sold my contracts of: Long Puts - Strike: 4.00 @ 0.22, 12-12-2021, for 0.70 per contract. I completed this in order to avoid the eat away of theta over the coming weeks. I believe in locking in my profits even though I project BNGO to continue to fall well into December. Current Options Positions Short Calls - Strike 5.00 @ 1.21, 21-01-2022 Long Puts - Strike 2.00 @ 0.05, 21-01-2022 Short Calls - Strike 6.00 @0.21, 21-01-2022 Current Stock Positions @5.97 @4.00
NASDAQ:BNGO
by braydenboyko
1
Trading Idea - #BionanoGenomicsSELL, SELL, SELL! Entry: 3.34 USD Target: 1.57 USD (profit +50%) Stop: 4.16 USD Bionano Genomics, is a genome analysis company. It offers instruments based on their Saphyr technology to scientists and clinics doing genetic research. 1.) Even at its current price, Bionano is an expensive stock. Sales for the first three quarters of 2021 were up 250% from a year ago. But they totaled less than $11.7 million. Operating losses were also up 76%, to over $48 million. The company was still putting $6.5 million into research expenses during the third quarter. Sales and general administrative expenses have nearly doubled from a year ago. 2.) BNGO's momentum indicator fell below the 0 mark on 15 November 2021. This is an indication that the share could enter a new downward movement. The probability of a decline is 90 %. 3.) The Moving Average Convergence Divergence Histogram (MACD) for BNGO turned negative on 10 November 2021. This could be a sign that the share will continue to move downwards in the coming weeks. 4.) BNGO has moved below its 50-day moving average on 09 November 2021, which may provide further downward pressure.
NASDAQ:BNGOShort
by Traderherz-Analytics
When Will BNGO Reverse? A look into S&DNASDAQ:BNGO Hello all, short article today about the play of Supply and Demand on BNGO. My current positions as always will be listed at the bottom of the page. The laws of Supply and Demand suggest that the two are inversely related, When supply increases demand decreases and vice versa. When looking at BNGO we have seen a steady decline in price over the last eight or so months. The interesting part to me is the fact that investors have bought far more than selling in this decline. How can the price of something continue to decline even as people buy it. If investors began selling out of the stock heavily, and consistently, a drop in price would be to expected, as the supply of sellers far out matches the buyers. But in the case of BNGO The supply of sellers continues to be below that of the demand of the buyers. We must understand that the stock market is far more complex than just the laws of supply and demand, but these laws tie heavily into human nature. Can we calculate for when we will hit an equilibrium? Yes: According to the equilibrium price formula, while using the current price and volume as our demand curve, and the average price and volume since the start of the decline. The output of those calculations is as follows: Demand curve: P = 3.85 - 6,470,000 Q Supply Curve: P = 5.79 + 9,447,878 Q Equilibrium Price: 4.64 This suggests we are currently under bought, also known as being in the "Supply Shortage" Zone. This means that soon enough there will be far to little shares to buy and no enough sellers, and the only way to pull back to the equilibrium price is to raise the price of the shares. All of this considers that the demand for BNGO will continue to rise, if the demand for BNGO were to turn negative, this price would not be accurate. So what do you think about a 4.64 price target? Does it align with your short term thoughts on where this price will go? (The S&D graph is displayed in blue on the chart) Current Positions In BNGO: Stock positions @5.97 Stock Positions @4.00 Short Call options @1.21 for a strike of $5, for 21-01-2022. Long Put options @0.22 for a strike of $4, for 17-12-2021. This is to hedge against short term downside lost. Long Put Options @0. 05 for a strike of $2, for 21-01-2022. to protect against a major free fall in price. Short Call options @0.21 for a strike of $6, for 21-01-2022. This is my most recent addition to continue generating income on my long position- and to help pay for the continuation of purchasing put options against a free fall.
NASDAQ:BNGO
by braydenboyko